Literature DB >> 11309154

A role for complement C5 in organism containment and granulomatous response during murine tuberculosis.

J K Actor1, E Breij, R A Wetsel, H Hoffmann, R L Hunter, C Jagannath.   

Abstract

The molecular mechanisms underlying protective granuloma formation and control of bacterial growth during infection with Mycobacterium tuberculosis (MTB) are not yet completely understood. MTB-infected mice with natural deficiency in complement component C5 are unable to develop productive granulomatous responses, and are impaired in limiting organism growth within the lung. To address the molecular basis for this histologic dysfunction, congenic complement C5-sufficient (B10.D2-H2d H2-T18c Hcl/nSnJ) and complement C5-deficient strains (B10.D2-H2d H2-T18c Hco/oSnJ) congenic mice were infected with Mycobacterium tuberculosis, and cytokine and chemokine responses were examined. Twelve and 28 days after infection, lungs showed elevated messages for multiple inflammatory cytokines in both congenic strains. Interleukin (IL)-12(p40) mRNA was also induced during infection in C5-deficient mice, although levels were significantly decreased compared to C5-sufficient congenics. C5-deficient mice also demonstrated reduced KC, MIP-2, IP-10, and MCP-1 mRNA. The defect may directly involve C5-mediated effects on macrophage responses; C5-deficient bone marrow derived macrophages had significantly reduced secretion of KC, MIP-1 alpha and MIP-2 compared to C5-sufficient macrophages following in vitro infection. These findings indicate a role for C5 in mediation of chemotactic and activation events that are the basis for granulomatous responses during murine tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309154     DOI: 10.1046/j.1365-3083.2001.00902.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

1.  Genetic control of immune-mediated necrosis of Mycobacterium avium granulomas.

Authors:  Manuela Flórido; Rui Appelberg
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes.

Authors:  Christine Keller; Reinhard Hoffmann; Roland Lang; Sven Brandau; Corinna Hermann; Stefan Ehlers
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.

Authors:  Kerry J Welsh; April N Abbott; Shen-An Hwang; Jessica Indrigo; Lisa Y Armitige; Michael R Blackburn; Robert L Hunter; Jeffrey K Actor
Journal:  Microbiology (Reading)       Date:  2008-06       Impact factor: 2.777

4.  A defect in the synthesis of Interferon-γ by the T cells of Complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis.

Authors:  Mary Anne Mashruwala; Amanda K Smith; Devin R Lindsey; Margaret Moczygemba; Rick A Wetsel; John R Klein; Jeffrey K Actor; Chinnaswamy Jagannath
Journal:  Tuberculosis (Edinb)       Date:  2011-12-05       Impact factor: 3.131

5.  A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential.

Authors:  Robert H Copenhaver; Eliud Sepulveda; Lisa Y Armitige; Jeffrey K Actor; Audrey Wanger; Steven J Norris; Robert L Hunter; Chinnaswamy Jagannath
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 6.  TB research at UT-Houston--a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis.

Authors:  Robert L Hunter; Lisa Armitige; Chinnaswamy Jagannath; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2009-12       Impact factor: 3.131

7.  Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid.

Authors:  J Scott Ferguson; Jeremy J Weis; Jennifer L Martin; Larry S Schlesinger
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis.

Authors:  Shen-An Hwang; Katarzyna M Wilk; Monika Budnicka; Margaret Olsen; Yogesh A Bangale; Robert L Hunter; Marian L Kruzel; Jeffrey K Actor
Journal:  Vaccine       Date:  2007-07-27       Impact factor: 3.641

9.  Complement factor C7 contributes to lung immunopathology caused by Mycobacterium tuberculosis.

Authors:  Kerry J Welsh; Cole T Lewis; Sydney Boyd; Michael C Braun; Jeffrey K Actor
Journal:  Clin Dev Immunol       Date:  2012-07-30

Review 10.  Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous Pathology.

Authors:  Jeffrey K Actor
Journal:  Mediators Inflamm       Date:  2015-12-14       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.